All Stories

  1. The role of competition and price in the decision o to invest in drug personalisation.
  2. Competition in the provision of hospital care: Are mixed markets a valid alternative?
  3. Value-based drug price schemes: a welfare analysis
  4. Decentralisation and waste flows: A welfare approach
  5. The redistributive effects of copayment (superticket): evidence from Lombardy
  6. Claims for devoluton may be driven by a reduction in regional income redistribution?
  7. Regulation strategies for the provision of goods Governmment make affordable to all the population
  8. Rationing in health care provision: a welfare approach
  9. Patient mobility and health care quality when regions and patients differ in income
  10. The Dynamics of Pharmaceutical Regulation and R&D Investments
  11. Optimal dynamic tax evasion: A portfolio approach
  12. Devolution and grant-in-aid design for the provision of impure public goods
  13. Patient mobility in the context of austerity and an enlarged EU: The European Court of Justice's ruling in the Petru Case
  14. Tax evasion and uncertainty in a dynamic context
  15. Drug Prices and Incentives to Innovation by the Pharmaceutical Industry
  16. A hedonic price analysis for the Italian wine in the domestic market
  17. Editorial Note
  18. Patient mobility, health care quality and welfare
  19. Should I pay for your risky behaviours? Evidence from London
  20. Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria
  21. Health care expenditure decisions in the presence of devolution and equalisation grants
  22. Erratum to: Standardised pre-competitive screening of athletes in some European and African countries: the SMILE study
  23. Two-part payments for the reimbursement of investments in health technologies
  24. Determinants of the price for the Italian red wine
  25. Pricing schemes for new drugs: A welfare analysis
  26. Health Care Provision and Patient Mobility
  27. Imperial College London Business School Questionnaire
  28. Patients’ Mobility Across Borders: A Welfare Analysis
  29. Cross Border Health Care Provision: Who Gains, Who Loses
  30. Optimal dynamic tax evasion
  31. Definition of a prospective payment system to reimburse emergency departments
  32. Standardised pre-competitive screening of athletes in some European and African countries: the SMILE study
  33. Patient selection in a mixed oligopoly market for health care: the role of the soft budget constraint
  34. Tax audits, fines and optimal tax evasion in a dynamic context
  35. Soft budget constraints in health care: evidence from Italy
  36. Not a good buy: Value for money of prescription drugs sold on the Internet
  37. Rent Extraction through Alternative Forms of Competition in the Provision of Paternalistic Goods
  38. Pricing strategies for Italian red wine
  39. From local to global public goods: How should externalities be represented?
  40. Emotional decision-makers and anomalous attitudes towards information
  41. Strategic costs and preferences revelation in the allocation of resources for health care
  42. Consequences on welfare of using health care restrictions
  43. Marketing and pricing strategies of online pharmacies
  44. Investment decisions in hospital technology when physicians are devoted workers
  45. Emotions in physician agency
  46. INVESTMENT IN HOSPITAL CARE TECHNOLOGY UNDER DIFFERENT PURCHASING RULES: A REAL OPTION APPROACH
  47. EXIT, CHOICE OR LOYALTY: PATIENT DRIVEN COMPETITION IN PRIMARY CARE
  48. Tax Evasion and the Cost of Public Sector Activities
  49. Regulating internal markets for hospital care
  50. Il costo del diabete: l’esperienza dell’ASL di Brescia
  51. Public Health Care with Waiting Time Revisited
  52. Hospital Health Care: Pricing and Quality Control in a Spatial Model with Asymmetry of Information
  53. Patients' migration across regions: the case of Italy
  54. Optimal payment schemes for physicians
  55. Decentralized Budgeting Procedures for Public Expenditure
  56. Pricing Policies in the Pharmaceutical Sector
  57. The provision of impure public goods in a non-competitive market
  58. Does Government Expenditure Crowd Out Private Consumption in Italy? Evidence from a Microeconomic Model
  59. The Effect of Deficit in a Multicountry Model with Perfect Mobility of Capital
  60. Developments in Local Government Finance: Theory and Policy
  61. NHS contracts: An agency approach
  62. ACCOUNTABILITY AND THE INTERNAL MARKET
  63. The estimation of British local government expenditure decisions under a piecewise linear budget constraint
  64. Fiscal Autonomy, Grants-in-Aid and Expenditure of Local Governments
  65. Optimizing the level of grant support for local government: An application of a behavioral model
  66. Asymmetry of Information in Public Finance
  67. LOCAL AUTHORITY EXPENDITURE DECISIONS: A MAXIMUM LIKELIHOOD ANALYSIS OF BUDGET SETTING IN THE FACE OF PIECEWISE LINEAR BUDGET CONSTRAINTS *
  68. ACCOUNTABILITY AND THE POLL TAX: THE IMPACT ON LOCAL AUTHORITY BUDGETS OF THE REFORM OF LOCAL GOVERNMENT FINANCE IN ENGLAND
  69. ACCOUNTABILITY AND THE POLL TAX: THE IMPACT ON LOCAL AUTHORITY BUDGETS OF THE REFORM OF LOCAL GOVERNMENT FINANCE IN ENGLAND
  70. An incremental budgeting model of local public expenditure setting in the presence of piecewise linear budget constraints
  71. Does the flypaper model stick? A test of the relative performance of the flypaper and conventional models of local government budgetary behaviour
  72. An Assessment of the Regional Impact of the Introduction of a Community Charge (or Poll Tax) in England
  73. The Impact of Party Politics on Patterns of Service Provision in English Local Authorities
  74. Regulation Strategies for Public Service Provision
  75. Waste Disposal and Decentralisation: A Welfare Approach
  76. Optimal Copayment Strategies in a Public Health Care System
  77. Dutch First Price Auctions for Public Service Provision
  78. Regulation Strategies in the Provision of Health Care
  79. Drug Pricing in a Regulated Market
  80. Impure Public Goods Provision in a Federal Fiscal System
  81. Optimal Dynamic Tax Evasion: A Portfolio Approach
  82. Public Sector Cost Inflation through Tax Evasion
  83. Optimal Dynamic Tax Evasion: A Portfolio Approach
  84. La Nuova Riforma Federalista
  85. Drug Pricing and Risk Sharing Agreements
  86. Strategic Costs and Preferences Revelation in the Allocation of Resources for Medical Treatments
  87. Rent Extraction Through Alternative Forms of Competition in the Provision of Merit and Impure Public Goods
  88. Welfare Properties of Restrictions to Health Care Services Based on Cost Effectiveness
  89. Fiscal Federalism and Grant-in-Aid Design for the Provision of Impure Public Goods
  90. Patients' Migration Across Regions: The Case of Italy
  91. Exit, Choice or Loyalty: Patient Driven Competition in Primary Care
  92. Hospital Care Organisation in Italy: A Theoretical Assessment of the Reform
  93. Pricing Drugs in a Regulated Market: A Bargaining Approach
  94. The Dynamics of Pharmaceutical Regulation and R&D Investments
  95. Public Expenditure Determination in a Mixed Market for Health Care
  96. Horizontal and Vertical Cream Skimming in the Health Care Market
  97. A Taxonomy of Cream Skimming in the Provision of Hospital Care
  98. Grants in Aid to Local Government: Median Voter and Political Biases
  99. Paternalistic Goods to Improve Income Distribution: A Political Economy Approach
  100. Hedonic Price for the Italian Red Wine: A Panel Analysis
  101. Soft Budget Constraint in Health Care: Evidence from Italy
  102. Hedonic Price for the Italian Red Wine: A Panel Analysis
  103. Fiscal Federalism, Patient Mobility and the Soft Budget Constraint
  104. From Local to Global Public Goods: How Should We Write the Utility Function
  105. Investment in Hospital Care Technology Under Different Purchasing Rules: A Real Option Approach
  106. Hospital Health Care: Cost Reimbursement and Quality Control in a Spatial Model with Asymmetry of Information
  107. Internal markets for hospital care: cost and quality control in a spatial competition model
  108. Quality and Investment Decisions in Hospital Care when Physicians are Devoted Workers
  109. It Takes Three to Tango: Soft Budget Constraint and Cream Skimming in the Hospital Care Market
  110. Static and Dynamic Efficiency of Irreversible Health Care Investments Under Alternative Payment Rules
  111. Static and Dynamic Efficiency of Irreversible Health Care Investments Under Alternative Payment Rules
  112. Shifting the Risk in Pricing and Reimbursement Schemes? A Model of Risk-Sharing Agreements for Innovative Drugs
  113. Patient Mobility, Health Care Quality and Welfare
  114. Delay is Not the Answer: Waiting Time in Health Care & Income Redistribution
  115. Devolution in the Provision of Merit and Impure Public Goods: Who Gains, Who Loses
  116. A Note on Optimal Tax Evasion in the Presence of Merit Goods
  117. THE EFFECT OF DEFICIT IN A MULTICOUNTRY MODEL WITH PERFECT MOBILITY OF CAPITAL
  118. The Regional Organization of Hospital Care in Italy: The Effects of Asymmetry of Information and Soft Budget Constraint Rules
  119. Waiting Time and Public Health Care: A Comment to 'Public Health Care with Waiting Time: The Role of Supplementary Private Health Care'
  120. Pricing and Marketing Strategies of On Line Pharmacies
  121. A Welfare Analysis of Rationing in Health Care Provision
  122. Oligopolistic Competition for the Provision of Hospital Care
  123. Would Less Solidarity Justify Present Calls for Devolution?
  124. Pricing Policies When Patients are Heterogeneous: A Welfare Analysis
  125. Timely, Cheap, or Risk Free? The Effect of Regulation on the Price and the Availability of New Drugs